Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Fabric Protocol Fabric Protocol +18.73%
#4 Cysic Cysic +17.50%
#5 Bedrock Bedrock +10.70%
#6 Cap Cap +8.99%
#7 stake.link stake.link +6.21%
#8 Perle Perle +5.03%
#9 Pons Pons +4.86%
#10 Test Test +4.23%
Coin of the day
EXOD EXOD
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Psyence Group Inc. Psyence Group Inc.

Psyence Group Inc.

PSYG
Classifica tra le azioni #38237
Psyence Group Inc. is a life sciences biotechnology company primarily engaged... Psyence Group Inc. is a life sciences biotechnology company primarily engaged in the commercial cultivation and production of psilocybin mushrooms. This naturally sourced psilocybin is intended for therapeutic applications, addressing a broad spectrum of mental health conditions and other medical ailments. The company is actively formulating pharmaceutical-grade psilocybin treatments designed to mitigate psychological trauma and recognized disorders such as anxiety, depression, post-traumatic stress disorder (PTSD), and the emotional distress linked to grief and bereavement. Furthermore, Psyence Group develops, distributes, and sells over-the-counter functional mushroom nutraceuticals, entirely free of psilocybin, under its GOODMIND brand. Established in 2019, the company maintains its headquarters in Toronto, Canada.
Prezzo delle azioni
$0.08765138
Ultima sincronizzazione: 2025-12-23
Capitalizzazione di mercato
$1.11M
Variazione (1 giorno)
0.45%
Variazione (1 anno)
-21.85%
Paese
CA
Scambia Psyence Group Inc. (PSYG)

Categoria

Healthcare
Storico del prezzo dell'azione per Psyence Group Inc. (PSYG)
Prezzo di chiusura più alto: $0.09 il 2025-12-01

Prezzo di chiusura più basso: $0.17 il 2021-01-01
Storico del prezzo dell'azione di Psyence Group Inc. dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 10.55%
2025 -20.78%
2024 -39.49%
2023 111.53%
2022 -39.61%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $1.18K 68.58%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $260.38 47.41%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $249.16 20.55%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $470.54 41.86%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $135.64 61.07%
US